| # | Drug | Count |
|---|---|---|
| 0 | MEDROXYPROGESTERONE ACETATE | 773 |
| 1 | CONJUGATED ESTROGENS | 693 |
| 2 | ESTROGENS, CONJUGATED | 693 |
| 3 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 374 |
| 4 | ESTRADIOL | 190 |
| 5 | ESTRADIOL GEL 0.1% | 67 |
| 6 | ESTRADIOL TRANSDERMAL | 67 |
| 7 | ESTRADIOL, | 67 |
| 8 | LEVONORGESTREL | 55 |
| 9 | INTERFERON BETA-1A | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FENOPROFEN CALCIUM | 1 | 0.0204 |
| 1 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 374 | 0.0159 |
| 2 | CONJUGATED ESTROGENS | 693 | 0.0119 |
| 3 | ESTROGENS, CONJUGATED | 693 | 0.0117 |
| 4 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 4 | 0.0108 |
| 5 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 4 | 0.0108 |
| 6 | ESTRADIOL/NORETHINDRONE ACETATE | 20 | 0.0102 |
| 7 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 7 | 0.0031 |
| 8 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 9 | ESTRADIOL | 190 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Estrogen [EPC] | 833 |
| 1 | Progestin [EPC] | 62 |
| 2 | Progestin-containing Intrauterine System [EPC] | 57 |
| 3 | Aromatase Inhibitor [EPC] | 53 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 42 |
| 5 | Interferon beta [EPC] | 31 |
| 6 | Progesterone [EPC] | 25 |
| 7 | Kinase Inhibitor [EPC] | 23 |
| 8 | Benzodiazepine [EPC] | 21 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen [EPC] | 833 | 0.0045 |
| 1 | Progesterone [EPC] | 25 | 0.0011 |
| 2 | Aromatase Inhibitor [EPC] | 53 | 0.0005 |
| 3 | Estrogen Receptor Antagonist [EPC] | 18 | 0.0004 |
| 4 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 5 | Androgen [EPC] | 9 | 0.0003 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 3 | 0.0003 |
| 7 | Progestin [EPC] | 62 | 0.0002 |
| 8 | Interferon beta [EPC] | 31 | 0.0002 |
| 9 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |